Notably, while our findings position IREB2 as a driver of COPD‐to‐lung cancer progression, paradoxically, several reports suggest high IREB2 expression in established lung cancer may associate with improved prognosis. This evidence concerns the gene IREB2 and chronic obstructive pulmonary disease.